These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 2737791)

  • 41. Cimetidine hydrochloride compatibility. II: room temperature stability in intravenous infusion fluids.
    Yuhas EM; Lofton FT; Mayron D; Baldinus JG; rosenberg HA
    Am J Hosp Pharm; 1981 Jun; 38(6):879-81. PubMed ID: 7246564
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cross-sectional study of potential incompatibility of intravenous medications in a neonatal intensive care unit in Indonesia.
    Mahendra AD; Hanifah S; Sari CP
    Farm Hosp; 2023; 47(1):16-19. PubMed ID: 36707307
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Visual compatibility of fludarabine phosphate with antineoplastic drugs, anti-infectives, and other selected drugs during simulated Y-site injection.
    Trissel LA; Parks NP; Santiago NM
    Am J Hosp Pharm; 1991 Oct; 48(10):2186-9. PubMed ID: 1781478
    [No Abstract]   [Full Text] [Related]  

  • 44. Compatibility of amifostine with selected drugs during simulated Y-site administration.
    Trissel LA; Martinez JF
    Am J Health Syst Pharm; 1995 Oct; 52(20):2208-12. PubMed ID: 8564592
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Utility of a Compatibility Chart for Continuous Infusions in the Intensive Care Unit.
    Kondo M; Tanaka C; Tagami T; Nagano M; Sugaya K; Tagui N; Kaneko J; Kudo S; Kuno M; Unemoto K; Takase H
    J Nippon Med Sch; 2022; 89(2):227-232. PubMed ID: 35545550
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cimetidine hydrochloride compatibility. III: Room temperature stability in drug admixtures.
    Yuhas EM; Lofton FT; Rosenberg HA; Mayron D; Baldinus JG
    Am J Hosp Pharm; 1981 Dec; 38(12):1919-22. PubMed ID: 7325173
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Stability of aztreonam and ampicillin sodium-sulbactam sodium in 0.9% sodium chloride injection.
    Belliveau PP; Nightingale CH; Quintiliani R
    Am J Hosp Pharm; 1994 Apr; 51(7):901-4. PubMed ID: 8017440
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Visual compatibility of ciprofloxacin lactate with five broad-spectrum antimicrobial agents during simulated Y-site injection.
    Tucker DR; Sieradzan R
    Am J Hosp Pharm; 1988 Sep; 45(9):1910-1. PubMed ID: 3228127
    [No Abstract]   [Full Text] [Related]  

  • 49. Simulated Y-site compatibility of atosiban acetate with selected intravenous drugs.
    Jiménez-Lozano I; Larrosa-García M; Boix-Montañés A; Bautista SC; Poy MJC
    Eur J Obstet Gynecol Reprod Biol; 2022 Aug; 275():106-109. PubMed ID: 35779331
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Compatibility and stability of linezolid injection admixed with three cephalosporin antibiotics.
    Xu QA; Trissel LA; Williams KY
    J Am Pharm Assoc (Wash); 2000; 40(4):509-14. PubMed ID: 10932460
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Visual compatibility of amsacrine with selected drugs during simulated Y-site injection.
    Trissel LA; Chandler SW; Folstad JT
    Am J Hosp Pharm; 1990 Nov; 47(11):2525-8. PubMed ID: 2278268
    [No Abstract]   [Full Text] [Related]  

  • 52. The electrophysiologic effects of nicardipine hydrochloride in man.
    Schwartz AB; Moskowitz RM; Klausner SC
    Can J Cardiol; 1987; 3(1):14-7. PubMed ID: 3828891
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cimetidine hydrochloride compatibility. I: Chemical aspects and room temperature stability in intravenous infusion fluids.
    Rosenberg HA; Dougherty JT; Mayron D; Baldinus JG
    Am J Hosp Pharm; 1980 Mar; 37(3):390-2. PubMed ID: 7369222
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Y-site Physical Compatibility of Beta-blocker Infusions with Intensive Care Unit Admixtures.
    Foushee JA; Meredith P; Fox LM; Grace E
    Int J Pharm Compd; 2016; 20(4):328-332. PubMed ID: 28333677
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Assessment of the physical compatibility of injectable enrofloxacin with commonly used intravenous fluids and drugs during simulated Y-port administration.
    Aghili A; Thomovsky EJ; Johnson PA; Brooks AC; Pierce TJ; Gochenauer AE
    Am J Vet Res; 2021 May; 82(5):358-366. PubMed ID: 33904804
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Visual compatibility of perphenazine with various antimicrobials during simulated Y-site injection.
    Gasca M; Fanikos J; Souney PF
    Am J Hosp Pharm; 1987 Mar; 44(3):574-5. PubMed ID: 3565416
    [No Abstract]   [Full Text] [Related]  

  • 57. Stability of piperacillin sodium-tazobactam sodium and ranitidine hydrochloride in 0.9% sodium chloride injection during simulated Y-site administration.
    Choi JS; Burm JP; Jhee SS; Chin A; Ulrich RW; Gill MA
    Am J Hosp Pharm; 1994 Sep; 51(18):2273-6. PubMed ID: 7801988
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Compatibility of cefmetazole sodium with commonly used drugs during Y-site delivery.
    Hutchings SR; Rusho WJ; Tyler LS
    Am J Health Syst Pharm; 1996 Sep; 53(18):2185-8. PubMed ID: 8879326
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Visual compatibility of doxapram hydrochloride with drugs commonly administered via a Y-site in the intensive care nursery.
    Bell MS; Nolt DH
    Am J Health Syst Pharm; 2003 Jan; 60(2):193-4. PubMed ID: 12561666
    [No Abstract]   [Full Text] [Related]  

  • 60. Compatibility of acetaminophen with central nervous system medications during simulated Y-site injection.
    Hanifah S; Nugroho B; Chabib L
    Anaesthesiol Intensive Ther; 2020; 52(1):23-27. PubMed ID: 32024349
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.